{"id":"https://openalex.org/W2067660314","doi":"https://doi.org/10.1111/j.1464-5491.2004.01116.x","title":"Coronary heart disease risk assessment in diabetes mellitus: comparison of UKPDS risk engine with Framingham risk assessment function and its clinical implications","display_name":"Coronary heart disease risk assessment in diabetes mellitus: comparison of UKPDS risk engine with Framingham risk assessment function and its clinical implications","alternate_titles":[],"publication_year":2004,"publication_date":"2004-01-22","ids":{"openalex":"https://openalex.org/W2067660314","doi":"https://doi.org/10.1111/j.1464-5491.2004.01116.x","mag":"2067660314","pmid":"https://pubmed.ncbi.nlm.nih.gov/15008833"},"language":"en","primary_location":{"id":"doi:10.1111/j.1464-5491.2004.01116.x","doi":"https://doi.org/10.1111/j.1464-5491.2004.01116.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1464-5491.2004.01116.x","pdf_url":null,"source":{"id":"https://openalex.org/S72944096","display_name":"Diabetic Medicine","issn_l":"0742-3071","issn":["0742-3071","1096-9136","1464-5491"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetic Medicine","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2067660314"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5037158081","display_name":"Soon H Song","orcid":"https://orcid.org/0000-0001-5316-1797","observed_orcids":["https://orcid.org/0000-0001-5316-1797"]},"institutions":[{"id":"https://openalex.org/I2800993931","display_name":"Hull Royal Infirmary","ror":"https://ror.org/02njpkz73","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2800043709","https://openalex.org/I2800993931"]}],"countries":["GB"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"S. H. Song","raw_affiliation_strings":["Diabetes Centre, Hull Royal Infirmary, UK. soon_song@hotmail.com","Diabetes Centre, Hull Royal Infirmary, Hull and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Diabetes Centre, Hull Royal Infirmary, UK. soon_song@hotmail.com","institution_ids":["https://openalex.org/I2800993931"]},{"raw_affiliation_string":"Diabetes Centre, Hull Royal Infirmary, Hull and","institution_ids":["https://openalex.org/I2800993931"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5108370408","display_name":"Phil Brown","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801267896","display_name":"Scarborough General Hospital","ror":"https://ror.org/01xnhkz22","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2801267896","https://openalex.org/I4210113900"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"P. M. Brown","raw_affiliation_strings":["Scarborough Hospital, Scarborough, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Scarborough Hospital, Scarborough, UK","institution_ids":["https://openalex.org/I2801267896"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5037158081"],"corresponding_institution_ids":["https://openalex.org/I2800993931"],"apc_list":{"value":4870,"currency":"USD","value_usd":4870},"apc_paid":null,"fwci":4.0332,"has_fulltext":false,"cited_by_count":72,"citation_normalized_percentile":{"value":0.94143928,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":98},"biblio":{"volume":"21","issue":"3","first_page":"238","last_page":"245"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.4957999885082245,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.4957999885082245,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.33059999346733093,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T14212","display_name":"Health Promotion and Cardiovascular Prevention","score":0.13760000467300415,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/coronary-heart-disease-risk-assessment","display_name":"coronary heart disease risk assessment","score":0.878000020980835},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9620000123977661},{"id":"https://openalex.org/keywords/ukpds-risk-engine","display_name":"UKPDS risk engine","score":0.9959999918937683},{"id":"https://openalex.org/keywords/framingham-risk-function","display_name":"Framingham risk equation","score":0.8259999752044678},{"id":"https://openalex.org/keywords/statin-initiation","display_name":"statin initiation","score":0.6129999756813049},{"id":"https://openalex.org/keywords/aspirin","display_name":"aspirin","score":0.7329999804496765},{"id":"https://openalex.org/keywords/primary-prevention","display_name":"primary prevention","score":0.8140000104904175},{"id":"https://openalex.org/keywords/nice-guidance","display_name":"NICE guidelines","score":0.8690000176429749},{"id":"https://openalex.org/keywords/risk-thresholds","display_name":"risk thresholds","score":0.7400000095367432},{"id":"https://openalex.org/keywords/cardiovascular-risk-prediction","display_name":"cardiovascular risk prediction","score":0.6079999804496765}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9125722646713257},{"id":"https://openalex.org/C11783203","wikidata":"https://www.wikidata.org/wiki/Q5478027","display_name":"Framingham Risk Score","level":3,"score":0.6834485530853271},{"id":"https://openalex.org/C2776839432","wikidata":"https://www.wikidata.org/wiki/Q954845","display_name":"Statin","level":2,"score":0.6205030679702759},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.601712167263031},{"id":"https://openalex.org/C2779256446","wikidata":"https://www.wikidata.org/wiki/Q33959","display_name":"Nice","level":2,"score":0.5887662768363953},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.577176570892334},{"id":"https://openalex.org/C12174686","wikidata":"https://www.wikidata.org/wiki/Q1058438","display_name":"Risk assessment","level":2,"score":0.549565315246582},{"id":"https://openalex.org/C2777628954","wikidata":"https://www.wikidata.org/wiki/Q18216","display_name":"Aspirin","level":2,"score":0.5395187139511108},{"id":"https://openalex.org/C2780920962","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"United Kingdom Prospective Diabetes Study","level":4,"score":0.464820921421051},{"id":"https://openalex.org/C120195587","wikidata":"https://www.wikidata.org/wiki/Q2138790","display_name":"Absolute risk reduction","level":3,"score":0.4499845504760742},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.4374432861804962},{"id":"https://openalex.org/C2910068830","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 Diabetes Mellitus","level":3,"score":0.2743965685367584},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.20331010222434998},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.08013090491294861},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0798555314540863},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.07475727796554565},{"id":"https://openalex.org/C38652104","wikidata":"https://www.wikidata.org/wiki/Q3510521","display_name":"Computer security","level":1,"score":0.0},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.0},{"id":"https://openalex.org/C199360897","wikidata":"https://www.wikidata.org/wiki/Q9143","display_name":"Programming language","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001241","descriptor_name":"Aspirin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D003327","descriptor_name":"Coronary Disease","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D003327","descriptor_name":"Coronary Disease","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D003430","descriptor_name":"Cross-Sectional Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003925","descriptor_name":"Diabetic Angiopathies","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":true},{"descriptor_ui":"D003925","descriptor_name":"Diabetic Angiopathies","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011320","descriptor_name":"Primary Health Care","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D012737","descriptor_name":"Sex Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017410","descriptor_name":"Practice Guidelines as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018570","descriptor_name":"Risk Assessment","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D019161","descriptor_name":"Hydroxymethylglutaryl-CoA Reductase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1111/j.1464-5491.2004.01116.x","doi":"https://doi.org/10.1111/j.1464-5491.2004.01116.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1464-5491.2004.01116.x","pdf_url":null,"source":{"id":"https://openalex.org/S72944096","display_name":"Diabetic Medicine","issn_l":"0742-3071","issn":["0742-3071","1096-9136","1464-5491"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetic Medicine","raw_type":"journal-article"},{"id":"pmid:15008833","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15008833","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetic medicine : a journal of the British Diabetic Association","raw_type":"Comparative Study"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":28,"referenced_works":["https://openalex.org/W424467158","https://openalex.org/W1972182005","https://openalex.org/W1972566357","https://openalex.org/W1989969519","https://openalex.org/W2005281896","https://openalex.org/W2031968478","https://openalex.org/W2063449239","https://openalex.org/W2086322879","https://openalex.org/W2089866062","https://openalex.org/W2091630536","https://openalex.org/W2094451166","https://openalex.org/W2101302799","https://openalex.org/W2117191092","https://openalex.org/W2119243222","https://openalex.org/W2129750583","https://openalex.org/W2136486607","https://openalex.org/W2137323125","https://openalex.org/W2137638424","https://openalex.org/W2155598961","https://openalex.org/W2162642883","https://openalex.org/W2167844544","https://openalex.org/W2331274940","https://openalex.org/W2493886745","https://openalex.org/W4231820866","https://openalex.org/W4237762834","https://openalex.org/W4239570539","https://openalex.org/W4285719527","https://openalex.org/W4301518376"],"related_works":["https://openalex.org/W2021460484","https://openalex.org/W2018107996","https://openalex.org/W3180543179","https://openalex.org/W1900936736","https://openalex.org/W2588627409","https://openalex.org/W2070635529","https://openalex.org/W7096639207","https://openalex.org/W2093130968","https://openalex.org/W2016099143","https://openalex.org/W2587884608"],"abstract_inverted_index":{"AIMS:":[0],"To":[1],"assess":[2],"differences":[3,63],"between":[4],"absolute":[5,56],"coronary":[6],"heart":[7],"disease":[8],"(CHD)":[9],"risks":[10,59],"calculated":[11,125],"by":[12,84,116],"Joint":[13],"British":[14],"Societies":[15],"(JBS)":[16],"risk":[17,21,107,123,131,162,168,178,215,224],"calculator":[18],"and":[19,23,72,76,153],"UKPDS":[20,122,167],"engine":[22,124,169],"its":[24],"impact":[25,233],"on":[26,234],"CHD":[27,58,106,130,177,220],"primary":[28,219],"prevention":[29],"management":[30],"in":[31,51,64,98,204],"diabetes":[32],"mellitus":[33],"(DM).":[34],"METHODS:":[35],"Seven":[36],"hundred":[37],"Type":[38],"2":[39],"DM":[40],"patients":[41,68,94,147,172,207],"without":[42],"arterial":[43],"complications":[44],"were":[45,60,88,158],"identified":[46,69,95,143,170],"from":[47,110,180],"nine":[48],"general":[49],"practices":[50],"the":[52,65,99,166,176,193,223,235],"Scarborough":[53,100],"area.":[54],"Their":[55],"10-year":[57,129],"calculated.":[61],"The":[62,90],"proportion":[66,91,213],"of":[67,92,105,146,164,192],"for":[70,79,96,151,173,184,196,226],"aspirin":[71,152],"statin":[73,97,154,185,227],"under":[74,208],"JBS":[75],"National":[77],"Institute":[78],"Clinical":[80],"Excellence":[81],"(NICE)":[82],"guidelines":[83],"these":[85],"two":[86],"methods":[87,142,201],"determined.":[89,120],"additional":[93,190],"population":[101,195],"as":[102],"a":[103,161,230],"consequence":[104],"threshold":[108,163,179,225],"reduction":[109],"30":[111,181],"to":[112,148,182],"15%":[113,183],"(as":[114],"recommended":[115],"NICE)":[117],"was":[118],"also":[119],"RESULTS:":[121],"significantly":[126],"higher":[127],"mean":[128],"(UKPDS":[132],"vs.":[133,136],"JBS,":[134],"21.5":[135],"18.3%,":[137],"P":[138],"<":[139],"0.0001).":[140],"Both":[141,200],"approximately":[144],"65%":[145],"be":[149],"eligible":[150],"if":[155],"NICE":[156,209],"recommendations":[157],"followed.":[159],"At":[160],"30%,":[165],"more":[171],"statin.":[174],"Reducing":[175],"initiation":[186],"will":[187],"identify":[188],"an":[189],"0.5%":[191],"total":[194],"this":[197],"treatment.":[198],"CONCLUSIONS:":[199],"are":[202],"comparable":[203],"identifying":[205],"at-risk":[206],"recommendations.":[210],"A":[211],"high":[212],"has":[214,229],"levels":[216],"that":[217],"merits":[218],"prevention.":[221],"Lowering":[222],"treatment":[228],"small":[231],"numerical":[232],"whole":[236],"population.":[237]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2067660314","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":6},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
